CEL Selling General Administrative from 2010 to 2024
| CVM Stock | USD 1.43 0.01 0.70% |
Selling General Administrative | First Reported 1988-12-31 | Previous Quarter 2.2 M | Current Value 2.1 M | Quarterly Volatility 983.1 K |
Check CEL SCI financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CEL main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.8 M, Interest Expense of 815.6 K or Selling General Administrative of 5.2 M, as well as many exotic indicators such as Price To Sales Ratio of 717, Dividend Yield of 0.0025 or PTB Ratio of 3.6. CEL financial statements analysis is a perfect complement when working with CEL SCI Valuation or Volatility modules.
CEL | Selling General Administrative |
Latest CEL SCI's Selling General Administrative Growth Pattern
Below is the plot of the Selling General Administrative of CEL SCI Corp over the last few years. It is CEL SCI's Selling General Administrative historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CEL SCI's overall financial position and show how it may be relating to other accounts over time.
| Selling General Administrative | 10 Years Trend |
|
Selling General Administrative |
| Timeline |
CEL Selling General Administrative Regression Statistics
| Arithmetic Mean | 8,480,210 | |
| Geometric Mean | 7,475,834 | |
| Coefficient Of Variation | 39.52 | |
| Mean Deviation | 2,653,159 | |
| Median | 7,998,573 | |
| Standard Deviation | 3,351,318 | |
| Sample Variance | 11.2T | |
| Range | 12.8M | |
| R-Value | 0.35 | |
| Mean Square Error | 10.6T | |
| R-Squared | 0.12 | |
| Significance | 0.20 | |
| Slope | 261,378 | |
| Total Sum of Squares | 157.2T |
CEL Selling General Administrative History
About CEL SCI Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include CEL SCI income statement, its balance sheet, and the statement of cash flows. CEL SCI investors use historical funamental indicators, such as CEL SCI's Selling General Administrative, to determine how well the company is positioned to perform in the future. Although CEL SCI investors may use each financial statement separately, they are all related. The changes in CEL SCI's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on CEL SCI's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on CEL SCI Financial Statements. Understanding these patterns can help to make the right decision on long term investment in CEL SCI. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Selling General Administrative | 10.4 M | 5.2 M |
Pair Trading with CEL SCI
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CEL SCI position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEL SCI will appreciate offsetting losses from the drop in the long position's value.Moving together with CEL Stock
| 0.82 | EVOK | Evoke Pharma | PairCorr |
| 0.68 | EWTX | Edgewise Therapeutics Financial Report 9th of May 2024 | PairCorr |
Moving against CEL Stock
| 0.71 | OGN | Organon | PairCorr |
| 0.69 | VKTX | Viking Therapeutics | PairCorr |
| 0.69 | KRYS | Krystal Biotech Financial Report 13th of May 2024 | PairCorr |
| 0.67 | HCWB | HCW Biologics | PairCorr |
| 0.6 | DYAI | Dyadic International Financial Report 8th of May 2024 | PairCorr |
The ability to find closely correlated positions to CEL SCI could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CEL SCI when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CEL SCI - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CEL SCI Corp to buy it.
The correlation of CEL SCI is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CEL SCI moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CEL SCI Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CEL SCI can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of CEL SCI Correlation against competitors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for CEL Stock analysis
When running CEL SCI's price analysis, check to measure CEL SCI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CEL SCI is operating at the current time. Most of CEL SCI's value examination focuses on studying past and present price action to predict the probability of CEL SCI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CEL SCI's price. Additionally, you may evaluate how the addition of CEL SCI to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is CEL SCI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.69) | Revenue Per Share 0.001 | Quarterly Revenue Growth (0.63) | Return On Assets (0.52) | Return On Equity (1.58) |
The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.